Search Results (1,193)

Artificial intelligence (AI) is reshaping the field of diagnostic radiology; however, its applications in interventional radiology and pediatric interventional radiology (PIR) remain limited despite clear clinical needs and the rich multimodal data environment characteristic of pediatric procedural care. In this narrative review, I summarize the current state of AI technologies relevant to PIR and outline future perspectives for their clinical integration. Peer-reviewed literature and position statements identified through MEDLINE/PubMed, Embase, Scopus, and major society publications up to the first quarter of 2026 are synthesized, focusing on AI applications across the PIR care pathway, including dose-sparing image acquisition and reconstruction, automated image interpretation and computer-aided diagnosis, data-driven procedural planning and navigation, and post-procedural risk prediction and monitoring. After briefly introducing core machine learning and deep learning concepts, pediatric-specific challenges are discussed, including radiation sensitivity, growth-related anatomical variability, regulatory constraints, and the scarcity of large, annotated datasets, as well as existing and emerging applications along the PIR care pathway: AI-assisted dose reduction and image reconstruction, automated image interpretation, segmentation, and computer-aided diagnosis; data-driven procedural planning, including three-dimensional modelling, augmented reality, AI-enabled/AI-adjacent robotics, and AI-directed procedural navigation; and post-procedural risk prediction and outcome monitoring. Finally, emerging paradigms, including explainable AI, federated learning, and multimodal integration, are highlighted, and research priorities, collaborative frameworks, and governance principles required to ensure safe, equitable, and effective AI deployment in PIR are outlined. In doing so, this review delineates the current evidence gaps and priority directions for clinically meaningful AI adoption in PIR. Although AI has the potential to improve patient care, it has not yet been specifically designed, validated, or deployed in children. Existing work demonstrates feasibility across the PIR workflow, but most tools remain weakly linked to pediatric clinical endpoints. Full article

Integrating neural and muscular signals into wearable robotics enables adaptive assistance during real-world tasks. This study proposes a multimodal neural interface for passive exoskeletons that combines electroencephalography (EEG) and electromyography (EMG) signals to classify motor gestures and estimate real-time cognitive and muscular effort, supported by finite-element-based biomechanical modeling. The system was implemented on the Ottobock Shoulder X passive exoskeleton© and validated using synchronous EEG–EMG acquisition via the LiveAmp platform©, a commercially available platform that was not developed specifically for this study. A hybrid CNN–LSTM architecture with deep fusion was employed to enhance robustness and responsiveness under realistic operating conditions. This study proposes a multimodal neural interface for the software-level adaptive assistance of passive upper-limb exoskeletons. While the physical device maintains a static mechanical profile, the proposed digital framework achieves adaptation by interpreting the user’s physiological and motor states. Ten healthy participants performed three functional tasks (screwing, moving the box, and lifting the box) under five assistive conditions. Finite element modeling (FEM) was used to characterize the torque–angle relationship of the passive exoskeleton and to support the interpretation of experimentally observed assistive torque profiles. The FEM model, used as an offline biomechanical analysis tool to aid in the interpretation of experimental results, has not been integrated into the real-time control loop. Results showed an average classification accuracy of 90%, an F1-score of 0.85, and inference latency below 180 ms, confirming real-time applicability. Cognitive indices such as the Cognitive Load Index (CLI) and Frontal Asymmetry Index (FAI) enabled adaptive modulation of assistance strategies without requiring active actuation, thereby preserving the device’s intrinsic passive nature. Comparative torque analysis highlighted the ergonomic benefits of passive systems in mid-range postures, while Finite Element Method (FEM) supported analysis clarified their limitations under highly dynamic loads compared to active solutions. These findings advance multimodal brain–machine interfaces for wearable robotics by integrating physiological sensing, deep learning, and biomechanical modeling, offering a safe, energy-efficient, and adaptive approach with potential rehabilitation, occupational ergonomics, and human–robot applications. Full article

This review examines the emerging role of machine learning (ML) in pharmaceutical chemistry, with emphasis on molecular design, synthetic feasibility, and structure–property–performance (SPP) relationships. By enabling pre-synthesis prediction of physicochemical properties, reaction pathways, and pharmaceutical performance, ML can reduce empirical trial-and-error experimentation and support more efficient exploration of chemical space. A structured narrative review design with PRISMA-aligned systematic search elements was used to evaluate 101 studies, enabling transparent literature identification, eligibility screening, and thematic synthesis across heterogeneous ML applications in pharmaceutical chemistry. This review examines structure–property relationships (SPRs) and property–performance relationships (PPRs), with emphasis on key pharmaceutical endpoints such as solubility, permeability, stability, dissolution, and bioavailability. An integrated SPP framework is proposed to connect molecular structure, intermediate properties, and final performance outcomes while incorporating retrosynthetic analysis and experimental feedback and closed-loop optimization. Recent frontier developments are also discussed, including molecular foundation models, multimodal language–graph models, diffusion-based molecular generation, E(3)-equivariant models, and MolMIM-like latent-space optimization. This review also covers co-folding and joint ligand–protein modeling, Boltz-2-like affinity prediction, AlphaFold 3-related biomolecular interaction modeling, and absorption, distribution, metabolism, excretion, and toxicity (ADMET) prediction. Key limitations include dataset leakage, benchmark inconsistency, assay variability, conformational and protonation-state effects, reproducibility challenges, regulatory constraints, and the gap between computational prediction and prospective experimental validation. Future progress is expected to depend on hybrid physics–ML models, uncertainty-aware prospective validation, autonomous experimentation, explainable artificial intelligence, and sustainability-aware molecular design. Overall, ML is evolving from a predictive tool into a chemically informed decision-support framework for rational, synthesis-aware, and experimentally validated pharmaceutical development. Full article

Wearable healthcare technologies are transforming the healthcare landscape by enabling remote, real-time health data collection, supporting early diagnosis, personalizing treatment plans, and reducing healthcare costs and medical burdens. Central to these advancements are wearable sensors, which continuously capture physiological data such as heart rate, temperature, activity levels, and biomarker concentrations. However, the large volume and complexity of this data demand effective processing to extract meaningful medical insights. Artificial intelligence (AI) and machine learning (ML) have significantly enhanced the capabilities of wearable sensors by enabling advanced data analysis, pattern recognition, and predictive modeling. AI-enhanced wearable sensors can detect early signs of health issues, such as heart attacks, chronic diseases, and mental health conditions like stress, often before clinical symptoms become apparent. This review examines the integration of AI/ML models with wearable sensors across physical activity recognition, stress assessment, cardiovascular monitoring, personal exposure monitoring, and sweat biomarker detection. Unlike prior application-centered reviews, we emphasize methodological and translational evaluation by comparing task formulations, sensing modalities, dataset scale, validation protocols, performance metrics, and deployment constraints across domains. We further discuss advanced architectures, multimodal fusion, explainable AI, edge deployment, privacy and regulatory considerations, and the translational gap between research prototypes and clinically deployable wearable AI systems. Full article

Arthropathies are a major global health challenge because of their high prevalence, chronic progression, and significant impact on quality of life and health systems. Therefore, prompt and accurate diagnosis is critical for slowing disease progression and improving outcomes. Traditional imaging modalities, such as ultrasound and magnetic resonance imaging, suffer from significant limitations, including operator dependence, limited accessibility, high cost, and limited reproducibility. Infrared thermography has become a promising non-invasive imaging technique for identifying thermal variations linked to inflammatory and metabolic processes. Advances in quantitative thermography, automated segmentation, and artificial intelligence have greatly enhanced its clinical applicability. This review summarizes recent advances in thermography-based biomarkers, including region-of-interest-derived metrics, asymmetry indices, hotspot burden, spatial and texture descriptors, and composite thermographic scores. It discusses the role of machine learning and deep learning in prediction, phenotyping, and multimodal integration with clinical, laboratory, and imaging data. Heterogeneity of protocols, variability in measurements, domain shift, validation design, overfitting, and reporting quality are also addressed. Overall, thermography combined with AI is highly promising as an adjunct to early diagnosis, assessment of disease activity, and follow-up in arthropathies. However, clinical application at a large scale requires strict standardization, external validation, transparent reporting, and well-elucidated, reproducible analytical processes. Full article

Precision agriculture increasingly relies on machine learning applied to high-resolution data acquired by unmanned aerial vehicles (UAVs) to support crop monitoring, stress detection, and yield forecasting. This survey presents a structured review of machine learning methods for UAV-enabled precision agriculture and organizes over 100 peer-reviewed studies within a unified four-dimensional taxonomy defined by sensing modality, data type, model family, and analytical task. The taxonomy enables systematic comparison across RGB, multispectral, hyperspectral, LiDAR, and IoT data sources and across classical machine learning, deep learning, hybrid sequential models, and emerging transformer-based architectures. We analyze how modeling choices interact with data characteristics to influence robustness, cross-environment generalization, computational efficiency, and deployment feasibility on UAV and edge platforms. Recurring challenges include limited labeled data, domain shift across seasons and fields, multimodal heterogeneity, occlusion, and real-time processing constraints. We identify emerging research directions, including data-efficient learning, representation-level multimodal fusion, domain adaptation, lightweight architectures for embedded deployment, and uncertainty aware decision support. By formalizing the landscape through a unified taxonomy, this survey provides a foundation for designing scalable, robust, and deployable machine learning systems for next-generation precision agriculture. Full article

Whole-slide imaging has transformed histopathology into a data-rich domain; however, many computational pathology models encode tissue morphology within latent representations, limiting interpretability, reproducibility, and generalization. This review positions histomics as an intermediate phenotype representation layer linking histological images with downstream clinical inference through structured descriptors of tissue morphology, spatial organization, and tissue architecture. Unlike prior reviews focused primarily on feature extraction or predictive performance, the study adopts a representation-centric perspective of histomics. A taxonomy of histomic features across biological scales is presented, and artificial intelligence frameworks, including machine learning, deep learning, weakly supervised learning, and multimodal approaches, are systematically examined. Key challenges, including segmentation dependence, feature instability, aggregation variability, and domain shift, are critically analyzed alongside emerging developments in foundation models, representation learning, and multimodal pathology. The review provides a unified framework for understanding histomic representations and identifies future directions for developing robust, interpretable, and generalizable computational pathology systems. Full article

The convergence of artificial intelligence (AI), explainable AI (XAI), and neuroscience is fostering new opportunities for understanding both machine and biological intelligence through interpretable and human-centered learning paradigms. In this Perspective, we introduce XAI2Brain as a conceptual framework for brain–AI alignment, positioning mechanistic interpretability as an intermediate layer connecting neural network representations, human understanding, and neuroscience-inspired AI design. Rather than viewing XAI solely as a post hoc transparency tool, we emphasize its emerging role in enabling mechanistic analysis of internal model representations, concept-level reasoning, and interactive human–AI alignment. We define XAI2Brain as a multi-level conceptual framework rather than a deployable system, explicitly aimed at structuring brain–AI alignment across representation-level, mechanism-level, and interaction-level perspectives. We survey the evolution of XAI methodologies—from feature attribution and concept-based explanations to mechanistic and human-centric interpretability approaches—and discuss how these methods may support bidirectional knowledge transfer between AI systems and cognitive neuroscience. Importantly, we adopt a cautious stance on brain–AI analogy, explicitly recognizing that artificial neural representations are not equivalent to biological neural representations, and instead focusing on functional and informational correspondences rather than structural equivalence. Unlike conventional human-in-the-loop or reinforcement learning from human feedback paradigms that primarily optimize behavioral outputs, XAI2Brain focuses on cognitively interpretable and mechanistically grounded alignment between AI systems and human reasoning processes. This alignment promotes interactive human-in-the-loop intelligence, empowering humans to comprehend, guide, and refine AI systems, while enabling AI systems to better interpret human instructions, intentions, and contextual reasoning. We further discuss the challenges of scaling explainability to large generative and multimodal models, including issues of interpretability robustness, cognitive compatibility, evaluation, and ethical accountability. We also highlight key limitations of current mechanistic interpretability methods, including explanation instability, representation superposition, and lack of causal guarantees, underscoring that these challenges remain open research problems. Rather than proposing a complete artificial brain architecture, this Perspective outlines a research roadmap toward more interpretable, adaptive, and neuroscience-inspired AI systems capable of supporting future brain–AI integration and collaborative intelligence. We additionally clarify that this work follows a narrative perspective review methodology with structured thematic synthesis of the literature. By framing explainability as a bridge between mechanistic AI understanding, cognitive science, and human-centered interaction, XAI2Brain highlights the importance of interpretable alignment for the next generation of brain-inspired AI systems. Full article

Cancer-related cognitive impairment (CRCI), also known as chemobrain or chemofog, is characterized by subjective and/or objective changes in attention, executive functions, memory, and processing speed in patients with non-CNS cancers, particularly women with breast cancer. This structured narrative review synthesizes current evidence on mechanisms, neuropsychological assessment, neuroimaging correlates, clinical and demographic risk factors, emerging artificial intelligence and machine learning applications, and non-pharmacological approaches to CRCI in breast cancer. A structured literature search was conducted using PubMed/MEDLINE, PsycInfo, and Clinical Key up to May 2026, with emphasis on studies published between 2023 and 2026. Peer-reviewed English-language studies involving adult breast cancer populations and addressing predefined thematic domains of CRCI were considered. Given the heterogeneity of study designs, assessment tools, interventions, and outcomes, the findings were synthesized narratively. Current evidence supports a multifactorial model of CRCI involving neurobiological, treatment-related, psychological, and behavioral mechanisms. Neuroinflammation, endocrine disruption, oxidative stress, glial alterations, and structural or functional brain changes may contribute to cognitive symptoms; however, the strength of evidence varies, and many findings remain correlational or preclinical. Non-pharmacological interventions, including cognitive training, physical activity, mindfulness-based and psychological approaches, and multimodal digital programs, appear promising as supportive strategies. However, evidence remains heterogeneous, with benefits more consistently reported for patient-reported outcomes, fatigue, emotional distress, and quality of life than for objective neuropsychological performance. CRCI in breast cancer should be approached as a heterogeneous condition requiring early recognition, standardized assessment, and multidisciplinary supportive care. Future research should prioritize longitudinal designs, harmonized endpoints, and a clearer distinction between subjective and objective outcomes. Full article

Background: Respiratory diseases (RDs), including asthma, COVID-19, chronic obstructive pulmonary disease (COPD), and pneumonia, remain a major global health challenge, contributing substantially to global morbidity and mortality. Conventional diagnosis relies heavily on clinicians’ expertise to interpret respiratory sounds and radiographic images, a process that can be subjective, time-consuming, and prone to inter-observer variability. Recent advances in artificial intelligence (AI) and machine learning (ML) have enabled automated diagnostic approaches that can improve the efficiency, consistency, and scalability of respiratory disease detection. However, existing research remains fragmented across different data modalities. Methods: This review systematically analyzes recent studies on AI-based respiratory disease detection using both visual modalities (e.g., chest X-rays, computed tomography (CT) scans, and ultrasound) and audio modalities (e.g., cough and breath sounds). To provide a comprehensive perspective, the reviewed literature is organized using a unified taxonomy that categorizes existing approaches into three main groups: audio-based, visual-based, and audio–visual-based methods. In addition, two conceptual frameworks are proposed to illustrate representative pipelines for audio-based and visual-based respiratory disease classification. Results: The analysis reveals that most existing studies focus on single-modality approaches, while multimodal integration remains relatively underexplored. Only a limited number of studies combine audio and visual data within unified frameworks, primarily due to the scarcity of synchronized multimodal datasets collected from the same patients. The proposed taxonomy and conceptual frameworks provide a structured basis for comparing existing methods, identifying methodological trends, and highlighting key research gaps in multimodal respiratory disease detection. Conclusions: Future research should prioritize the development of multimodal datasets, robust evaluation protocols, and interpretable and lightweight AI models suitable for real-world clinical deployment. Advancing multimodal integration has the potential to significantly enhance the accuracy, reliability, and clinical applicability of AI-driven respiratory disease diagnosis systems. Full article

Antimicrobial resistance and biofilm-associated contamination continue to pose critical challenges in food safety and biomedical applications, necessitating the development of advanced antimicrobial materials with enhanced efficacy, safety, and functional adaptability. Antimicrobial nanomaterials offer versatile solutions due to their tunable physicochemical properties, surface engineering capabilities, and controlled release behaviors, enabling improved antimicrobial and antibiofilm performance across diverse systems. This review highlights the main advancements in AI-assisted design of antimicrobial nanomaterials, demonstrating how data-driven approaches are increasingly used to predict antimicrobial activity, optimize synthesis parameters, model nanotoxicity, integrate multimodal datasets, and improve interpretability through explainable AI frameworks. Key findings indicate that machine learning-guided strategies and autonomous experimental platforms significantly accelerate material optimization while reducing reliance on traditional trial-and-error methods. The review further summarizes the performance and mechanisms of major antimicrobial nanomaterial systems, including metal and metal oxide nanoparticles, metal–organic frameworks, polymeric nanocarriers, nanoemulsions, and hybrid nanostructures, with emphasis on their translational applications in food preservation, antimicrobial coatings, wound healing, implant protection, and drug delivery. Despite these advances, challenges remain in data quality, model generalizability, toxicity prediction, reproducibility, and regulatory translation. AI-enabled and data-driven frameworks provide a powerful pathway for accelerating the rational design and practical implementation of next-generation antimicrobial nanomaterials. Full article

Background: Sports injuries impose a substantial burden on athletes. Machine learning (ML) and deep learning (DL) methods, collectively referred to as artificial intelligence (AI), are increasingly applied to develop predictive models and targeted prevention strategies. Objective: This scoping review aimed to map contemporary trends in AI applications for sports injury prediction and personalised prevention strategies, critically appraising the existing methodological approaches and identifying future research directions. Methods: Following PRISMA-ScR guidelines, we systematically searched five electronic databases, i.e., PubMed, Web of Science, Institute of Electrical and Electronics Engineers Xplore, Scopus, and Google Scholar, for peer-reviewed studies published up to February 2026 that applied AI methods for injury prediction and/or prevention in athletic populations. Results: Thirty-nine studies were included. Tree-based ML algorithms were the most common (59% of studies) methods used, with reported area under the curve values ranging from 0.82 to 0.95. DL was used in 18% of studies, with one hybrid model reporting 92% accuracy. Integrating multi-modal data was associated with improved model performance in 37% of studies. Among included studies, AI-informed prevention strategies were associated with injury reductions ranging from 23% to 42%, derived from synthesis-level and single-centre intervention evidence, respectively. The key challenges identified were heterogeneous injury definitions, small sample sizes, and data privacy concerns. Conclusions: AI models can inform personalised injury prevention, but their clinical use is limited by methodological issues. Key limitations include heterogeneous injury definitions, small sample sizes, and a lack of external validation. Standardised protocols are needed to improve the reliability and application of these models in practice. Full article

In contemporary society, breast health has become a significant public health concern, particularly among women. According to statistics from the World Health Organization, both the incidence and mortality rates of breast tumors have steadily increased in recent years. Therefore, effective early-stage screening and postoperative monitoring are essential for maintaining breast health. However, conventional clinical diagnostic modalities are typically bulky, operationally complex, and unsuitable for continuous real-time monitoring, which limits their use in portable and everyday health management applications. To address these limitations, this study proposes a machine learning-integrated wearable piezoelectric sensing platform as an auxiliary tool for breast health assessment. The device consists of a PDMS matching layer embedded with flexible silver nanowires, a P(VDF-TrFE) piezoelectric layer, and a multi-channel low-noise signal acquisition circuit. It is capable of acquiring acoustic echo signals from tissue-mimicking environments and automatically evaluating signal validity using a convolutional neural network (CNN). By integrating piezoelectric sensing with deep learning-based signal analysis, the proposed system achieves a signal-to-noise ratio exceeding 70 dB and a real-time classification accuracy above 96% under controlled conditions. These results demonstrate that the platform provides a compact, portable, and intelligent approach for wearable sensing of mechanical heterogeneity and highlight its potential for future development in continuous biomedical monitoring technologies. Full article

In characterizing unconventional reservoirs, conventional Digital Rock Physics (DRP) has long been constrained by three fundamental bottlenecks: the trade-off between imaging resolution and field of view, challenges in reconstructing multiscale pore topology, and the prohibitive computational cost of direct numerical simulation (DNS) at the pore scale. The deep integration of artificial intelligence and rock physics has given rise to a new paradigm—Intelligent Digital Rock Physics (IDRP). This paper provides a systematic review of the evolutionary trajectory of IDRP, with a focus on how machine learning is reshaping the end-to-end workflow from imaging and segmentation to reconstruction and simulation. First, we survey image super-resolution and 3D pore structure generation techniques based on convolutional neural networks (CNNs), generative adversarial networks (GANs), and diffusion models, elucidating their mechanisms for surpassing optical diffraction limits and incorporating macroscopic petrophysical constraints. Second, we outline algorithmic strategies for fusing multi-source heterogeneous data (e.g., Micro-CT and SEM) and representing dual-porosity or multi-continuum systems. Third, we critically examine the application of machine learning surrogates in single- and multiphase flow prediction, highlighting how physics-informed machine learning (PIML) and reinforcement learning (RL)—by embedding governing equations such as Navier–Stokes or Muskat–Leverett into loss functions—achieve both computational acceleration and physical consistency. We further identify key limitations of current IDRP approaches, including insufficient validation of generated topological realism, narrow generalization across lithologies, inadequate representation of dynamic wettability, and limited model interpretability. Finally, we propose a forward-looking roadmap centered on multimodal foundation models for rocks, coupled with neural operators and uncertainty quantification frameworks, emphasizing the critical pathways for translating IDRP into engineering digital twins for unconventional hydrocarbon development, coalbed methane production enhancement, Enhanced Geothermal Systems, and geological CO₂ storage. This review offers a comprehensive reference for researchers at the intersection of geophysics, rock mechanics, and artificial intelligence. Full article

Background and Objectives: The COVID-19 pandemic disrupted cancer diagnosis and treatment pathways worldwide. Glioblastoma is an aggressive primary brain malignancy requiring timely multimodal care. This study evaluated survival outcomes among glioblastoma patients diagnosed before and during the COVID-19 pandemic and prepared a dataset for machine learning-based prediction of 12-month mortality. Materials and Methods: Patients aged ≥20 years diagnosed with glioblastoma between 2018 and 2021 were identified from the SEER database using ICD-O-3 histology codes 9440/3, 9441/3, and 9442/3. Patients were categorized as pre-COVID period (2018–2019) or COVID period (2020–2021). OS and CSS were evaluated using Kaplan–Meier curves, log-rank tests, and Cox regression models. Machine learning models predicted 12-month all-cause mortality using registry variables. Results: The final cohort included 9914 patients; 4819 were diagnosed pre-COVID and 5095 during COVID. Median OS was 11 months pre-COVID and 10 months during COVID; 12-month OS was 44.3% and 41.2%, respectively. Median CSS was 11 months in both periods; 12-month CSS was 46.9% and 44.1%, respectively. COVID-period diagnosis was modestly associated with poorer OS (adjusted HR 1.050, 95% CI 1.006–1.095, p = 0.025) and CSS (adjusted HR 1.048, 95% CI 1.003–1.095, p = 0.035). Machine learning models showed moderate discrimination for 12-month mortality prediction. Conclusions: Glioblastoma patients diagnosed during the COVID period had modestly poorer OS and CSS in conventional survival analyses; however, competing-risk analysis did not show a significant association with cancer-specific death. Registry-based machine learning models provided moderate 12-month mortality prediction, supporting their potential utility for population-level prognostic assessment. Full article